Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Bioheart (Sunrise, Fla.) raised the number of shares and lowered the proposed price range
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury